Hematological Biomarkers in COVID-19 Severity Assessment

Summary

Hematological biomarkers have emerged as accessible and cost-effective tools for stratifying risk in patients with COVID-19. Routine blood counts provide insight into the host inflammatory response, with neutrophilia and lymphopenia serving as hallmarks of severe disease. Composite indices such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and systemic inflammation index (SII) integrate these cellular changes to yield stronger prognostic signals than isolated parameters. Dynamic monitoring of these ratios can identify early deterioration, guide triage decisions and optimise allocation of critical care resources. Across diverse populations, elevated NLR and related indices have been linked to higher likelihood of intensive care admission, mechanical ventilation and in-hospital mortality. As global health systems continue to grapple with emerging SARS-CoV-2 variants and uneven vaccine coverage, reliable bedside biomarkers remain essential for personalised management and rapid escalation of therapy in high-risk individuals.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Hematological Biomarkers in COVID-19 Severity Assessment publication trend

The graph below shows the total number of articles in hematological biomarkers in covid-19 severity assessment across all publications each year (not limited to Nature Index journals).

Technical terms

Neutrophil-to-lymphocyte ratio (NLR): Ratio of absolute neutrophil count to absolute lymphocyte count, indicating balance between innate and adaptive immunity.

Platelet-to-lymphocyte ratio (PLR): Ratio of platelet count to lymphocyte count, reflecting inflammatory and thrombotic interplay.

Systemic inflammation index (SII): Composite measure calculated as neutrophils × platelets / lymphocytes, quantifying overall inflammatory burden.

Derived neutrophil-to-lymphocyte ratio (dNLR): Variation of NLR computed as neutrophils divided by the difference between total white cells and neutrophils, adjusting for lymphopenia.

Systemic inflammation response index (SIRI): Index combining neutrophil, monocyte and lymphocyte counts (neutrophils × monocytes / lymphocytes) to assess inflammatory response intensity.

References

  1. Systemic inflammation index, disease severity, and mortality in patients with COVID-19: a systematic review and meta-analysis. Frontiers in Immunology (2023).
  2. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Critical Care (2020).
  3. Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis. Frontiers in Immunology (2021).
  4. The Predictive Role of NLR, d-NLR, MLR, and SIRI in COVID-19 Mortality. Diagnostics (2022).
  5. Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients. Journal of Clinical Medicine (2022).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.